Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Wasserman Schultz, Debbie [D-FL-25]

Rep. Wasserman Schultz, Debbie [D-FL-25]

United States · Official source

Records

4,689 records where Rep. Wasserman Schultz, Debbie [D-FL-25] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 9432 (119th)referred

LIFT the BAR Act

United States · United States Congress · 24 June 2026

Bill· HRH.R. 9169 (119th)referred

PKD Cures Act

United States · United States Congress · 4 June 2026

Bill· HRH.R. 9094 (119th)referred

Florida Freeze Disaster Assistance Act of 2026

United States · United States Congress · 2 June 2026

Florida Freeze Disaster Assistance Act of 2026 This bill provides $3.5 billion in emergency funding for the Department of Agriculture (USDA) to provide block grants to certain states for losses of revenue, quality, or production of crops (including crops prevented from planting), trees, bushes, and vines as a consequence of a freeze or cold weather conditions. The bill specifies that the funding may only be made available for losses occurring in counties that received a disaster designation for freeze and related cold weather conditions issued by USDA on March 4, 2026. (This includes certain counties in Alabama, Florida, and Georgia.) The bill requires the assistance provided by the bill to include compensation to producers for losses of multi-year crops. The funds provided by this bill must be made available upon the request of a state department of agriculture or other appropriate state agency.

Bill· HRH.R. 9039 (119th)referred

PANA Act of 2026

United States · United States Congress · 26 May 2026

Resolution· HRESH.Res. 1251 (119th)passed

Calling on elected officials and civil society leaders to counter antisemitism and educate the public on the contributions of the Jewish-American community.

United States · United States Congress · 30 April 2026

This resolution calls on elected officials, faith leaders, and civil society leaders to condemn and counter acts of anti-Semitism. The resolution also honors the contributions of Jewish-American servicemembers and commits to ensuring all Americans, including Jewish Americans, can worship without fear of violence or persecution.

Bill· HRH.R. 8471 (119th)referred

PRIMATE Act

United States · United States Congress · 23 April 2026

Resolution· HRESH.Res. 1186 (119th)referred

Expressing the sense of the House of Representatives that President Donald Trump, his Special Envoy Steven Witkoff, and all Federal officials must comply with the Foreign Emoluments Clause of the Constitution by immediately turning over to the Department of the Treasury any payments received from the United Arab Emirates or any other foreign state and divest from all business interests linked to foreign governments.

United States · United States Congress · 16 April 2026

Bill· HRH.R. 8163 (119th)reported

Provider Reimbursement Stability Act of 2026

United States · United States Congress · 30 March 2026

Provider Reimbursement Stability Act of 2026 This bill allows for larger annual adjustments to the Medicare physician fee schedule. It also requires the Centers for Medicare & Medicaid Services (CMS) to make certain corrections to compensate for expenditures under the fee schedule that exceed a certain amount in a given year, and it limits how much certain adjustment factors may vary each year. Current law prohibits annual adjustments to the Medicare physician fee schedule that would result in a more than $20 million difference between the adjusted amount and the non-adjusted amount of total expenditures. The bill increases this threshold to $54.3 million beginning in 2027, with adjustments for inflation every five years beginning in 2032. Additionally, for certain services, the bill requires the CMS to determine the difference between expenditures based on estimated utilization of the service and expenditures based on actual utilization. If this difference exceeds a certain percentage of total expenditures under the fee schedule, the CMS must reconcile this difference by adjusting payments for the following year. This requirement applies to services for which payment was bundled with another service and there was a separate or add-on payment during the previous year. Finally, the CMS must update the prices and rates of each category of direct costs that affect payments (e.g., prices of equipment) at least every five years, with updates made to each category in the same year. The bill also prohibits the CMS from varying a certain adjustment factor by more than 2.5% each year.

Bill· HRH.R. 8055 (119th)referred

Extending WIC for New Moms Act

United States · United States Congress · 24 March 2026

Extending WIC for New Moms Act This bill amends the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) to extend the eligibility periods for breastfeeding and postpartum women. Specifically, a state program may elect to certify a breastfeeding woman for up to 24 months (currently 1 year) postpartum. The bill also expands the eligibility period for postpartum women to up to 24 months after termination of pregnancy (currently 6 months). The Department of Agriculture must submit a report to Congress evaluating the effect of these changes to the program on (1) maternal and infant health outcomes, (2) breastfeeding rates, and (3) qualitative evaluations of family experiences under WIC. 

Bill· HRH.R. 8016 (119th)referred

Forever Chemical Regulation and Accountability Act of 2026

United States · United States Congress · 19 March 2026

Forever Chemical Regulation and Accountability Act of 2026 This bill phases out the release and nonessential use of perfluoroalkyl or polyfluoroalkyl substances (PFAS) and addresses PFAS research, remediation, regulation, and enforcement. The Environmental Protection Agency (EPA) must require each manufacturer and user of PFAS to submit annual reports that include specified information about the essential (e.g., critical for health or safety reasons) and nonessential uses of PFAS by such entities. Not later than 10 years after the enactment of this bill, manufacturers and users must fully phase out nonessential uses of PFAS. The bill also establishes specified deadlines to phase out the sale of certain products containing PFAS; requires federal agencies, to the maximum extent practicable, to eliminate the procurement of products known to contain PFAS; imposes a 10-year phaseout of the release of PFAS above a certain threshold of detection; provides enforcement authority to the EPA regarding violations of the requirements of the bill, including through civil and criminal penalties; allows citizen suits against manufacturers and users of PFAS and the EPA; and addresses actions under state law related to damages from exposure to hazardous substances, including with regard to statutes of repose. The bill exempts from a bankruptcy petition’s automatic stay any proceeding against a non-debtor entity (e.g., a proceeding to obtain property from a non-debtor) with respect to a PBT claim (a claim relating to persistent, bioaccumulative, and toxic chemicals) against the non-debtor entity, the debtor, or the estate.